Clin Toxicol (Phila). 2014 Jan;52(1):1-12. doi: 10.3109/15563650.2013.872791.
Fatal poisoning data can reveal trends in the poisons encountered, which can help guide prescribing practices and product safety and other legislation, and more recently has helped to monitor the use of emerging drugs of abuse ( ‘ legal highs ’ ).
We searched Mortality Statistics – Injury and poisoning, Series DH4 (2000 – 2005), Mortality Statistics – Deaths registered in England and Wales, Series DR (2006 – 2011), and the Office for National Statistics drug poisoning database for information on fatal poisoning during 2000 – 2011. We also searched the Pubmed database for ‘ fatal ’ and ‘ poisoning ’ and ‘ England ’ and ‘ Wales ’ : this search yielded seven papers that gave relevant information on deaths reported during 2000 – 2011 that were not superseded by later publications. DEATHS FROM POISONING: The annual number of deaths from poisoning fell from 2000 (3092) to 2010 (2749), before increasing to 3341 in 2011. This increase was due in part to a change in the ICD coding relating to alcohol poisoning, suggesting that such deaths had been under-recorded previously. Although fatalities from dextropropoxyphene declined (287 in 2004 and 18 in 2011) following the withdrawal of co-proxamol (paracetamol [acetaminophen] and dextropropoxyphene [propoxyphene] mixture) during 2005 – 2007, deaths involving codeine and most notably tramadol (836 deaths during 2000 – 2011) increased. Deaths from paracetamol poisoning either alone, or with alcohol reached 89 in 2011, the lowest annual figure since 1974. However, in reality there has been no marked downward trend since 1999 despite reductions in pack size, continued publicity as to the dangers of paracetamol overdose, and improved liver failure treatment, including transplantation. The annual number of deaths from antidepressants remained relatively stable (median: 397, range: 335 – 469). Although the number of deaths from dosulepin [dothiepin] decreased (186 in 2000 and 49 in 2011), the number of deaths involving selective serotonin reuptake inhibitors increased (50 in 2000 and 127 in 2011). Although annual numbers of deaths involving diamorphine/morphine (88% unintentional) declined, deaths involving methadone (89% unintentional) increased and the total annual number of deaths from these drugs showed little change (2000: 1061, 2011: 995). Deaths involving amfetamine/metamfetamine remained relatively constant at about 50 annually, and whilst cocaine-related deaths fell by 48% during 2008 – 2011, and deaths involving MDMA and related compounds fell by 69% over this same period, deaths involving ‘ legal highs ’ , notably γ -hydroxybutrate/ γ -butyrolactone and ketamine, increased.
Alterations in the availability of paracetamol and of prescription drugs such as dextropropoxyphene and dosulepin have not been accompanied by decreases in the number of deaths from poisoning. Despite intense media and other interest, the annual number of deaths (250 – 300) involving ‘ recreational ’ drugs remains small in relation to the 1000 or so deaths a year from diamorphine and/or methadone.
致命中毒数据可以揭示所遇到的毒物趋势,这有助于指导处方实践和产品安全及其他法规的制定,最近还帮助监测新兴滥用药物(“合法兴奋剂”)的使用情况。
我们搜索了《死亡率统计——伤害和中毒》系列 DH4(2000-2005 年)、《死亡率统计——英格兰和威尔士登记的死亡》系列 DR(2006-2011 年)和国家统计局毒品中毒数据库,以获取 2000-2011 年期间致命中毒的信息。我们还在 Pubmed 数据库中搜索了“致命”和“中毒”以及“英格兰”和“威尔士”:该搜索产生了七篇论文,提供了 2000-2011 年期间报告的死亡相关信息,这些信息没有被后来的出版物所取代。
2000 年(3092 人)至 2010 年(2749 人),每年中毒死亡人数呈下降趋势,然后在 2011 年增加至 3341 人。这一增长部分归因于与酒精中毒相关的 ICD 编码的变化,表明此前此类死亡人数可能被低估了。尽管在 2005-2007 年期间,由于停止使用含有可待因和右丙氧芬的复方制剂(扑热息痛[对乙酰氨基酚]和右丙氧芬[丙氧芬]混合物),导致右丙氧芬的死亡率下降(2004 年 287 人,2011 年 18 人),但涉及可待因的死亡人数和更值得注意的曲马多(2000-2011 年期间有 836 人死亡)有所增加。单独使用或与酒精一起使用对乙酰氨基酚中毒导致的死亡人数在 2011 年达到 89 人,是自 1974 年以来的最低年度数字。然而,自 1999 年以来,尽管包装尺寸有所减少,持续宣传对乙酰氨基酚过量的危险,以及改善肝衰竭治疗,包括肝移植,实际情况并没有明显的下降趋势。抗抑郁药的年死亡人数仍然相对稳定(中位数:397,范围:335-469)。尽管多塞平[多虑平]的死亡人数减少(2000 年 186 人,2011 年 49 人),但涉及选择性 5-羟色胺再摄取抑制剂的死亡人数增加(2000 年 50 人,2011 年 127 人)。尽管涉及海洛因/吗啡(88%为非故意)的死亡人数有所下降,但涉及美沙酮(89%为非故意)的死亡人数有所增加,这些药物的总年死亡人数变化不大(2000 年:1061 人,2011 年:995 人)。涉及苯丙胺/苯丙胺的死亡人数保持相对稳定,每年约为 50 人,尽管 2008-2011 年期间可卡因相关死亡人数下降了 48%,而涉及 MDMA 和相关化合物的死亡人数同期下降了 69%,但涉及“合法兴奋剂”,特别是γ-羟基丁酸/γ-丁内酯和氯胺酮的死亡人数有所增加。
对扑热息痛和右旋丙氧芬等处方药物供应的改变并没有导致中毒死亡人数的减少。尽管媒体和其他方面的关注强烈,但涉及“娱乐性”药物的年度死亡人数(250-300 人)与每年约 1000 人因海洛因和/或美沙酮而死亡相比仍然很小。